The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFLX.L Regulatory News (FLX)

  • There is currently no data for FLX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

4 Aug 2022 07:00

RNS Number : 8500U
Falanx Group Limited
04 August 2022
 

This announcement contains inside information for the purposes of Article 7 of the UK version of Regulation (EU) No 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended ("MAR"). Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain

 

4 August 2022

 

FALANX GROUP LIMITED

(the "Company")

Trading Update

 

Falanx Group Limited (AIM: FLX), the AIM listed provider of cyber security services, is pleased to provide an update on its results for the year ended 31 March 2022 and the first quarter's trading to 30 June 2022.

 

Results for the Year Ended 31 March 2022 (continuing operations)

 

Revenues are expected to be c.£3.5m (2021: £3.1m) representing organic growth of c.14%, mainly arising from improved professional services revenues. The Company moved to a new cyber security monitoring platform (Triarii) during the year and this, combined with higher services utilisation, has increased the gross margin to c.40% (2021: c.32%). The Group expects to record a reduced adjusted EBITDA loss than in the previous year, despite having commenced an investment programme in the expansion of the cyber business following the disposal of the Assynt strategic intelligence divisions. The audit is very largely complete, no issues have been raised, and the audited results are expected to be announced in the middle of September 2022. 

 

Current Trading

 

The Group has been trading in line with management expectation since the start of the current financial year. Significant planned investment has taken place in the cyber division, particularly around sales and marketing expansion and product innovation. As a result of this, the business has established a far greater pipeline than in previous years. The pipeline is not only much larger in terms of financial value but also has a high level of advanced prospects and, most notably, the bulk of the pipeline now comprises recurring revenue opportunities for cyber security monitoring, including Triarii based on Microsoft Sentinel. Falanx continues to grow its channel business and has brought on dedicated resources to expand channel coverage. This investment has proved effective with new partners such as ESET, where opportunities have already been established for providing cyber security monitoring services to their MDR and EDR clients, as well as a much higher level of activity with longer standing partners.

 

New products have been launched for Continuous Vulnerability Scanning (CVS) and Retained Incident Response (R-IR) and these are expected to contribute to recurring revenues. These complement the previously launched Falanx: Cyber Exposure Level (f: CEL) tool which has been adopted by existing clients as well as creating a separate revenue opportunity with new customers.

 

Balance Sheet Position

 

At 30 June 2022, the Group had cash balances of £2.7m which were in line with budget. The Group has a normal working capital profile, HMRC legacy support around Covid-19 has been paid down save for a very small scheduled amount. The Board expects these cash balances to be sufficient for its organic growth plans.

 

Mike Read, CEO of Falanx, commented:

 

"We are very pleased with the Group's performance over the past few months which is benefiting from the focus on growing a pure play cyber security business. The recent investments in sales, marketing and new products has created a considerable pipeline of new business which is more significant than at any time in the Group's history. With a healthy balance sheet, we are able to focus on future growth and we are optimistic about outlook of the business."

 

Enquiries:

Falanx Group Limited

Alex Hambro Chairman

Mike Read CEO

Ian Selby CFO

Via IFC

WH Ireland Limited, Nomad and Broker

Mike Coe / Sarah Mather

 

+44 (0) 207 220 1666

 

IFC Advisory Ltd, Financial PR & IR

Graham Herring / Zach Cohen

+44 (0) 203 934 6630

 

 

About Falanx

Falanx Group Limited, is a cyber defence provider providing enterprise class defensive and offensive security solutions to SME. For further information: http://www.falanx.com/

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFSTTFIVIIF
Date   Source Headline
21st Dec 201812:45 pmRNSDirector/PDMR Shareholding
3rd Dec 20187:00 amRNSIssue of Equity Update - Replacement
30th Nov 20186:25 pmRNSIssue of Equity Update
30th Nov 201811:38 amRNSTotal Voting Rights
26th Nov 20181:06 pmRNSTR-1: notification of major holdings
20th Nov 20187:00 amRNSTR-1: notification of major holdings
16th Nov 20187:51 amRNSTR-1: notification of major holdings
16th Nov 20187:50 amRNSTR-1: notification of major holdings
14th Nov 20187:42 amRNSIssue of Equity
14th Nov 20187:00 amRNSINTERIM RESULTS for 6 Months to 30 September 2018
16th Oct 20187:00 amRNSFALANX AND SOLARWINDS PARTNERSHIP UPDATE
19th Sep 20187:00 amRNSInvestor Event
19th Sep 20187:00 amRNSSOLARWINDS MSP APPOINTS FALANX
21st Aug 20189:45 amRNSDirector / PDMR Shareholding
15th Aug 201811:35 amRNSDirector / PDMR Shareholding
15th Aug 201811:22 amRNSDirector / PDMR Shareholding
14th Aug 20184:40 pmRNSSecond Price Monitoring Extn
14th Aug 20184:35 pmRNSPrice Monitoring Extension
14th Aug 20187:00 amRNSAnnual Results for the Year-Ended 31 March 2018
31st Jul 20187:00 amRNSContract Announcement
17th Jul 20187:00 amRNSACQUISITION OF SECURESTORM LIMITED
10th Jul 20187:00 amRNSNotice of Results
16th May 20187:00 amRNSCONTRACT WINS AND TECHNOLOGY DEVELOPMENT
18th Apr 20187:00 amRNSCYBER SECURITY OPERATIONAL UPDATE
21st Mar 20182:38 pmRNSTR-1:Notification of Major Holdings
16th Mar 20187:00 amRNSGrant of Share Options
12th Mar 20187:00 amRNSManagement Structure and Directorate Change
6th Mar 20188:45 amRNSResult of Accelerated Bookbuild
6th Mar 20187:00 amRNSProposed ABB and Conditional Acquisition
2nd Mar 201811:57 amRNSStatement regarding Broker
7th Feb 20187:00 amRNSContract Wins
15th Jan 20188:37 amRNSContract Win and Directorate Change
20th Dec 20177:00 amRNSContract Win and Managed Services Update
20th Nov 20178:41 amRNSTR-1: Notification of of major holdings
17th Nov 20177:00 amRNSDirector/PDMR Shareholding
15th Nov 20177:00 amRNSInterim Results
14th Nov 20177:00 amRNSDirectorate Change & Notice of Results
18th Sep 20177:00 amRNSNon Regulatory - Cyber Partnership
13th Sep 20177:00 amRNSAppointment of Joint Broker
13th Sep 20177:00 amRNSProprietary MidGARD Platform launch
11th Sep 20177:00 amRNSAcquisition and Appointment of CTO
5th Sep 20177:00 amRNSOperational Update
21st Jul 20174:58 pmRNSTR-1: Notification of Major Interest in Shares
20th Jul 20171:31 pmRNSDirector/PDMR Shareholding
18th Jul 20177:00 amRNSManaging Director appointed for Stirling Assynt
10th Jul 20177:00 amRNSAnnual Results for the Year-Ended 31 March 2017
5th Jul 20177:31 amRNSAcquisition of Cloudified Ltd
23rd Jun 20178:36 amRNSNotice of Results
8th Jun 20171:50 pmRNSInvestor Evening
6th Jun 20177:00 amRNSAppointment of Joint-Broker

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.